thymia raised a $2.7M seed to expand its gamified AI mental health assessment

London-based health tech startup that uses gamified AI tools to assess mental health symptoms and support treatment plans

Gamified tools and explainable AI trained on a large proprietary dataset can make mental health assessments faster, more objective and more reliable for clinicians

$2.7M seed led by Kodori Ventures with Entrepreneur First, Syndicate Room, Calm/Storm, Form Ventures and angels; also raising via Crowdcube

CEO Dr Emilia Molimpakis, a neuroscientist, said her mission came from watching her best friend be misdiagnosed and struggle with depression at university. thymia says its dataset has more than one billion data points from over 5,000 people with conditions including depression, generalised anxiety and ADHD.

On 2023-07-27 thymia announced a $2.7M seed to expand to new markets and grow its capabilities. It claims its tool gives a more objective and empirical mental health assessment than current methods. Kodori Ventures said the company had recently expanded to four continents.

Existing assessment methods fail to capture the many ways conditions show up, leading to mis- or undiagnosis

A large proprietary dataset is the basis for the company's more objective assessments

Gamification is meant to collect objective signals beyond self-reports

Seed money funds expansion into new markets and added capabilities

Healthtech seeds rest on the claim that data beats clinical judgement alone; the dataset size and accuracy claims here are company statements, not clinical evidence.

As of 2023-07-27, thymia had closed a $2.7M seed, was crowdfunding, and said it was active on four continents.